15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer
Prostaglandin E2 (PGE2) can stimulate tumor progression by modulating several proneoplastic pathways, including proliferation, angiogenesis, cell migration, invasion, and apoptosis. Although steady-state tissue levels of PGE2 stem from relative rates of biosynthesis and breakdown, most reports exami...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2005-02, Vol.280 (5), p.3217-3223 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3223 |
---|---|
container_issue | 5 |
container_start_page | 3217 |
container_title | The Journal of biological chemistry |
container_volume | 280 |
creator | Backlund, Michael G. Mann, Jason R. Holla, Vijaykumar R. Buchanan, F. Gregory Tai, Hsin-Hsiung Musiek, Erik S. Milne, Ginger L. Katkuri, Sharada DuBois, Raymond N. |
description | Prostaglandin E2 (PGE2) can stimulate tumor progression by modulating several proneoplastic pathways, including proliferation, angiogenesis, cell migration, invasion, and apoptosis. Although steady-state tissue levels of PGE2 stem from relative rates of biosynthesis and breakdown, most reports examining PGE2 have focused solely on the cyclooxygenase-dependent formation of this bioactive lipid. Enzymatic degradation of PGE2 involves the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH). The present study examined a range of normal tissues in the human and mouse and found high levels of 15-PGDH in the large intestine. By contrast, the expression of 15-PGDH is decreased in several colorectal carcinoma cell lines and in other human malignancies such as breast and lung carcinomas. Consistent with these findings, we observe diminished 15-Pgdh expression in ApcMin+/– mouse adenomas. Enzymatic activity of 15-PGDH correlates with expression levels and the genetic disruption of 15-Pgdh completely blocks production of the urinary PGE2 metabolite. Finally, 15-PGDH expression and activity are significantly down-regulated in human colorectal carcinomas relative to matched normal tissue. In summary, these results suggest a novel tumor suppressive role for 15-PGDH due to loss of expression during colorectal tumor progression. |
doi_str_mv | 10.1074/jbc.M411221200 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1847633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820761831</els_id><sourcerecordid>67405180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-ce82d5fc08d2e2ac82e0f3ecead6462f37a363e9051260c5fc966c31309ac3443</originalsourceid><addsrcrecordid>eNqFkc1vEzEQxS0EoqHl2mO16oHbhvHXrveCVKVAKwVxoRI3y7Fnd11t1sHepOS_x1EiCgeEL5Y8P795M4-QSwpzCrV4_7iy8y-CUsYoA3hBZhQUL7mk31-SGQCjZcOkOiNvUnqEfERDX5MzKqVgFTQzsqSyvNu7GH7uNzGkyXSDGZ0fi1vsD88djiZhcZ-K2_A0lhG77WAmdEVGFmEIEe1khmJhRovxgrxqzZDw7ek-Jw-fPn5b3JXLr5_vFzfL0opGTqVFxZxsLSjHkBmrGELL0aJxlahYy2vDK44NSJpN2kw2VWU55dAYy4Xg5-TDUXezXa3RWRynaAa9iX5t4l4H4_XfldH3ugs7TZWoK86zwLuTQAw_tpgmvfbJ4pBnx7BNuqpFbq7gvyCtOQgu6wzOj6DNW0wR299uKOhDUjonpZ-Tyh-u_pzhGT9Fk4HrI9D7rn_yEfXKB9vjWjMFWmrO6KGtOkKY173zGHWyHnMWzh-S0S74fxn4BUkQriU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17304357</pqid></control><display><type>article</type><title>15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Backlund, Michael G. ; Mann, Jason R. ; Holla, Vijaykumar R. ; Buchanan, F. Gregory ; Tai, Hsin-Hsiung ; Musiek, Erik S. ; Milne, Ginger L. ; Katkuri, Sharada ; DuBois, Raymond N.</creator><creatorcontrib>Backlund, Michael G. ; Mann, Jason R. ; Holla, Vijaykumar R. ; Buchanan, F. Gregory ; Tai, Hsin-Hsiung ; Musiek, Erik S. ; Milne, Ginger L. ; Katkuri, Sharada ; DuBois, Raymond N.</creatorcontrib><description>Prostaglandin E2 (PGE2) can stimulate tumor progression by modulating several proneoplastic pathways, including proliferation, angiogenesis, cell migration, invasion, and apoptosis. Although steady-state tissue levels of PGE2 stem from relative rates of biosynthesis and breakdown, most reports examining PGE2 have focused solely on the cyclooxygenase-dependent formation of this bioactive lipid. Enzymatic degradation of PGE2 involves the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH). The present study examined a range of normal tissues in the human and mouse and found high levels of 15-PGDH in the large intestine. By contrast, the expression of 15-PGDH is decreased in several colorectal carcinoma cell lines and in other human malignancies such as breast and lung carcinomas. Consistent with these findings, we observe diminished 15-Pgdh expression in ApcMin+/– mouse adenomas. Enzymatic activity of 15-PGDH correlates with expression levels and the genetic disruption of 15-Pgdh completely blocks production of the urinary PGE2 metabolite. Finally, 15-PGDH expression and activity are significantly down-regulated in human colorectal carcinomas relative to matched normal tissue. In summary, these results suggest a novel tumor suppressive role for 15-PGDH due to loss of expression during colorectal tumor progression.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M411221200</identifier><identifier>PMID: 15542609</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Colon - enzymology ; Colorectal Neoplasms - metabolism ; Colorectal Neoplasms - physiopathology ; Cyclooxygenase 2 ; Dinoprostone - metabolism ; Gene Expression Regulation, Enzymologic ; Gene Expression Regulation, Neoplastic ; Humans ; Hydroxyprostaglandin Dehydrogenases - genetics ; Hydroxyprostaglandin Dehydrogenases - metabolism ; Membrane Proteins ; Mice ; Mice, Inbred C57BL ; Mice, Mutant Strains ; Prostaglandin-Endoperoxide Synthases - metabolism ; Tumor Cells, Cultured</subject><ispartof>The Journal of biological chemistry, 2005-02, Vol.280 (5), p.3217-3223</ispartof><rights>2005 © 2005 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-ce82d5fc08d2e2ac82e0f3ecead6462f37a363e9051260c5fc966c31309ac3443</citedby><cites>FETCH-LOGICAL-c495t-ce82d5fc08d2e2ac82e0f3ecead6462f37a363e9051260c5fc966c31309ac3443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847633/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847633/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15542609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Backlund, Michael G.</creatorcontrib><creatorcontrib>Mann, Jason R.</creatorcontrib><creatorcontrib>Holla, Vijaykumar R.</creatorcontrib><creatorcontrib>Buchanan, F. Gregory</creatorcontrib><creatorcontrib>Tai, Hsin-Hsiung</creatorcontrib><creatorcontrib>Musiek, Erik S.</creatorcontrib><creatorcontrib>Milne, Ginger L.</creatorcontrib><creatorcontrib>Katkuri, Sharada</creatorcontrib><creatorcontrib>DuBois, Raymond N.</creatorcontrib><title>15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Prostaglandin E2 (PGE2) can stimulate tumor progression by modulating several proneoplastic pathways, including proliferation, angiogenesis, cell migration, invasion, and apoptosis. Although steady-state tissue levels of PGE2 stem from relative rates of biosynthesis and breakdown, most reports examining PGE2 have focused solely on the cyclooxygenase-dependent formation of this bioactive lipid. Enzymatic degradation of PGE2 involves the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH). The present study examined a range of normal tissues in the human and mouse and found high levels of 15-PGDH in the large intestine. By contrast, the expression of 15-PGDH is decreased in several colorectal carcinoma cell lines and in other human malignancies such as breast and lung carcinomas. Consistent with these findings, we observe diminished 15-Pgdh expression in ApcMin+/– mouse adenomas. Enzymatic activity of 15-PGDH correlates with expression levels and the genetic disruption of 15-Pgdh completely blocks production of the urinary PGE2 metabolite. Finally, 15-PGDH expression and activity are significantly down-regulated in human colorectal carcinomas relative to matched normal tissue. In summary, these results suggest a novel tumor suppressive role for 15-PGDH due to loss of expression during colorectal tumor progression.</description><subject>Animals</subject><subject>Colon - enzymology</subject><subject>Colorectal Neoplasms - metabolism</subject><subject>Colorectal Neoplasms - physiopathology</subject><subject>Cyclooxygenase 2</subject><subject>Dinoprostone - metabolism</subject><subject>Gene Expression Regulation, Enzymologic</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Hydroxyprostaglandin Dehydrogenases - genetics</subject><subject>Hydroxyprostaglandin Dehydrogenases - metabolism</subject><subject>Membrane Proteins</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Mutant Strains</subject><subject>Prostaglandin-Endoperoxide Synthases - metabolism</subject><subject>Tumor Cells, Cultured</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1vEzEQxS0EoqHl2mO16oHbhvHXrveCVKVAKwVxoRI3y7Fnd11t1sHepOS_x1EiCgeEL5Y8P795M4-QSwpzCrV4_7iy8y-CUsYoA3hBZhQUL7mk31-SGQCjZcOkOiNvUnqEfERDX5MzKqVgFTQzsqSyvNu7GH7uNzGkyXSDGZ0fi1vsD88djiZhcZ-K2_A0lhG77WAmdEVGFmEIEe1khmJhRovxgrxqzZDw7ek-Jw-fPn5b3JXLr5_vFzfL0opGTqVFxZxsLSjHkBmrGELL0aJxlahYy2vDK44NSJpN2kw2VWU55dAYy4Xg5-TDUXezXa3RWRynaAa9iX5t4l4H4_XfldH3ugs7TZWoK86zwLuTQAw_tpgmvfbJ4pBnx7BNuqpFbq7gvyCtOQgu6wzOj6DNW0wR299uKOhDUjonpZ-Tyh-u_pzhGT9Fk4HrI9D7rn_yEfXKB9vjWjMFWmrO6KGtOkKY173zGHWyHnMWzh-S0S74fxn4BUkQriU</recordid><startdate>20050204</startdate><enddate>20050204</enddate><creator>Backlund, Michael G.</creator><creator>Mann, Jason R.</creator><creator>Holla, Vijaykumar R.</creator><creator>Buchanan, F. Gregory</creator><creator>Tai, Hsin-Hsiung</creator><creator>Musiek, Erik S.</creator><creator>Milne, Ginger L.</creator><creator>Katkuri, Sharada</creator><creator>DuBois, Raymond N.</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20050204</creationdate><title>15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer</title><author>Backlund, Michael G. ; Mann, Jason R. ; Holla, Vijaykumar R. ; Buchanan, F. Gregory ; Tai, Hsin-Hsiung ; Musiek, Erik S. ; Milne, Ginger L. ; Katkuri, Sharada ; DuBois, Raymond N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-ce82d5fc08d2e2ac82e0f3ecead6462f37a363e9051260c5fc966c31309ac3443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Colon - enzymology</topic><topic>Colorectal Neoplasms - metabolism</topic><topic>Colorectal Neoplasms - physiopathology</topic><topic>Cyclooxygenase 2</topic><topic>Dinoprostone - metabolism</topic><topic>Gene Expression Regulation, Enzymologic</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Hydroxyprostaglandin Dehydrogenases - genetics</topic><topic>Hydroxyprostaglandin Dehydrogenases - metabolism</topic><topic>Membrane Proteins</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Mutant Strains</topic><topic>Prostaglandin-Endoperoxide Synthases - metabolism</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Backlund, Michael G.</creatorcontrib><creatorcontrib>Mann, Jason R.</creatorcontrib><creatorcontrib>Holla, Vijaykumar R.</creatorcontrib><creatorcontrib>Buchanan, F. Gregory</creatorcontrib><creatorcontrib>Tai, Hsin-Hsiung</creatorcontrib><creatorcontrib>Musiek, Erik S.</creatorcontrib><creatorcontrib>Milne, Ginger L.</creatorcontrib><creatorcontrib>Katkuri, Sharada</creatorcontrib><creatorcontrib>DuBois, Raymond N.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Backlund, Michael G.</au><au>Mann, Jason R.</au><au>Holla, Vijaykumar R.</au><au>Buchanan, F. Gregory</au><au>Tai, Hsin-Hsiung</au><au>Musiek, Erik S.</au><au>Milne, Ginger L.</au><au>Katkuri, Sharada</au><au>DuBois, Raymond N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2005-02-04</date><risdate>2005</risdate><volume>280</volume><issue>5</issue><spage>3217</spage><epage>3223</epage><pages>3217-3223</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Prostaglandin E2 (PGE2) can stimulate tumor progression by modulating several proneoplastic pathways, including proliferation, angiogenesis, cell migration, invasion, and apoptosis. Although steady-state tissue levels of PGE2 stem from relative rates of biosynthesis and breakdown, most reports examining PGE2 have focused solely on the cyclooxygenase-dependent formation of this bioactive lipid. Enzymatic degradation of PGE2 involves the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH). The present study examined a range of normal tissues in the human and mouse and found high levels of 15-PGDH in the large intestine. By contrast, the expression of 15-PGDH is decreased in several colorectal carcinoma cell lines and in other human malignancies such as breast and lung carcinomas. Consistent with these findings, we observe diminished 15-Pgdh expression in ApcMin+/– mouse adenomas. Enzymatic activity of 15-PGDH correlates with expression levels and the genetic disruption of 15-Pgdh completely blocks production of the urinary PGE2 metabolite. Finally, 15-PGDH expression and activity are significantly down-regulated in human colorectal carcinomas relative to matched normal tissue. In summary, these results suggest a novel tumor suppressive role for 15-PGDH due to loss of expression during colorectal tumor progression.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15542609</pmid><doi>10.1074/jbc.M411221200</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 2005-02, Vol.280 (5), p.3217-3223 |
issn | 0021-9258 1083-351X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1847633 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Animals Colon - enzymology Colorectal Neoplasms - metabolism Colorectal Neoplasms - physiopathology Cyclooxygenase 2 Dinoprostone - metabolism Gene Expression Regulation, Enzymologic Gene Expression Regulation, Neoplastic Humans Hydroxyprostaglandin Dehydrogenases - genetics Hydroxyprostaglandin Dehydrogenases - metabolism Membrane Proteins Mice Mice, Inbred C57BL Mice, Mutant Strains Prostaglandin-Endoperoxide Synthases - metabolism Tumor Cells, Cultured |
title | 15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A49%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=15-Hydroxyprostaglandin%20Dehydrogenase%20Is%20Down-regulated%20in%20Colorectal%20Cancer&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Backlund,%20Michael%20G.&rft.date=2005-02-04&rft.volume=280&rft.issue=5&rft.spage=3217&rft.epage=3223&rft.pages=3217-3223&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M411221200&rft_dat=%3Cproquest_pubme%3E67405180%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17304357&rft_id=info:pmid/15542609&rft_els_id=S0021925820761831&rfr_iscdi=true |